SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001701541-20-000031
Filing Date
2020-11-10
Accepted
2020-11-10 07:13:29
Documents
3
Period of Report
2020-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdtx-8k_q32020.htm 8-K 23554
2 EX-99.1 bdtx-exhibit991q32020.htm EX-99.1 68135
3 GRAPHIC01 logo1.jpg GRAPHIC 14262
  Complete submission text file 0001701541-20-000031.txt   107262
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 201299606
SIC: 2836 Biological Products, (No Diagnostic Substances)